Centralized Management for NJ Taxotere Lawsuits Requested

Introduction

Taxotere linked thousands of lawsuits were centralized in October 2016 under MDL No. 2740 (in re Taxotere (Docetaxel) Products Liability Litigation) before Judge Kurt D. Engelhardt in the Eastern District of Louisiana; four cases have been selected to be a part of the first series of bellwether trials to begin in September.

With the mounting number of similar claims in New Jersey, a request for a centralized management has been requested by hundreds of women who filed their cases in New Jersey alleging that Sanofi-Aventis, the makers of the chemotherapy drug, failed to adequately warn consumers about the risk of permanent hair loss from using the breast cancer drug Taxotere.

Comments

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

Centralized Management for NJ Taxotere Lawsuits Requested